Published 3 hours ago • loading... • Updated 3 hours agoShow Less IconPrediction: Eli Lilly Could Be the Next $2 Trillion Drugmaker Summary by 24/7 Wall St.Eli Lilly just posted a 47.7% revenue surge while rivals like Novo Nordisk are watching earnings fall, and a fresh pipeline catalyst could push Lilly toward a valuation Wall Street has only seen from two companies in history.Share menu2 Articles2 ArticlesAllLeftCenter1RightSearch IconSort Icon24/7 Wall St.BizTocView articleCaret Right IconReposted by BizTocCenterFactualityOwnershipPrediction: Eli Lilly Could Be the Next $2 Trillion DrugmakerEli Lilly just posted a 47.7% revenue surge while rivals like Novo Nordisk are watching earnings fall, and a fresh pipeline catalyst could push Lilly toward a valuation Wall Street has only seen from two companies in history.3 hours ago·Lakewood, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources2Leaning Left0Leaning Right0Center1Last Updated2 hours agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Untracked biasFactuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageBizToc broke the news 3 hours ago on Friday, October 2, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsEli Lilly Plus IconPharma Plus IconStock Markets Plus IconIndianapolis Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsEli Lilly Plus IconPharma Plus IconStock Markets Plus IconIndianapolis Plus IconShow All